Combination of αCD4 antibody and retinal antigen injection induces long-term disease control in autoimmune uveitis

Combination of αCD4 antibody and retinal antigen injection induces long-term disease control in autoimmune uveitis

IntroductionAutoimmune uveitis is a sight-threatening inflammatory eye disease driven by immune dysregulation. We previously introduced a therapeutic strategy involving the in vivo induction of retinal-antigen-specific regulatory T cells (Tregs) via αCD4 antibody injection followed by administration...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dijie Qiao, Lu Zhang, Yajie Zhong, Dongmei Liu, Zilin Chen, Wai Po Chong, Jun Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Immunology
Subjects:	autoimmune uveitis immunotherapy regulatory T cells (Treg) long-term therapy chronic inflammation anti-CD4 antibody
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1636901/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tissue-specific roles of regulatory T cells: mechanisms of suppression and beyond along with emerging therapeutic insights in autoimmune indications
by: Bat-Erdene Jugder, et al.
Published: (2025-08-01)

CD2-targeted nanoparticles encapsulating IL-2 induce tolerogenic Tregs and TGF-β-producing NK cells that stabilize Tregs for long-term therapeutic efficacy in immune-mediated disorders
by: David A. Horwitz, et al.
Published: (2025-07-01)

Autoimmune uveitis: risk factors and issues of immunopathogenesis
by: I. V. Shirinsky, et al.
Published: (2025-01-01)

Neurofibromatosis type 1, sarcoidosis, and anterior uveitis: A simple coincidence or coexistence?—An interesting case report
by: Sujit Das
Published: (2025-01-01)

Evolution of Diagnostic Methods for Infectious and Non-Infectious Uveitis. Review
by: E. V. Boyko, et al.
Published: (2022-07-01)

Clinical and imaging characteristics of retinal neovascularization secondary to Behçet's uveitis
by: CHEN Xuelin, et al.
Published: (2025-02-01)

Determining the probability of spondyloarthritis in patients with uveitis
by: A. A. Godzenko, et al.
Published: (2024-11-01)

Application of ozone and plasmapheresis in complex treatment of uveitis
by: A. D. Chernyshyova
Published: (2009-06-01)

PROGRESSION AND OUTCOMES OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDILITIS
by: A. A. Godzenko, et al.
Published: (2014-10-01)

HLA-B27-ASSOCIATED UVEITIS: EPIDEMIOLOGY, CLINICAL PICTURE, AND COMPLICATIONS
by: T. V. Dubinina, et al.
Published: (2014-06-01)

Long-term effects of tocilizumab on retinal and choroidal inflammation in Birdshot uveitis
by: Lynn S. zur Bonsen, et al.
Published: (2024-11-01)

COURSE OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: A. A. Godzenko, et al.
Published: (2016-09-01)

Uveitis in Children
by: Rahul Bhatia, et al.
Published: (2021-10-01)

IMPACT OF THE THERAPY WITH TUMOR NECROSIS FACTOR α INHIBITORS ON THE FREQUENCY OF UVEITIS EXACERBATIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Alla A Godzenko, et al.
Published: (2014-03-01)

EXPERIENCE OF ADALIMUMAB TREATMENT IN PATIENT WITH JUVENILE ANKYLOSING SPONDYLITIS AND UVEITIS
by: E. V. Mitenko, et al.
Published: (2012-02-01)

Antigen‐specific polyfunctional cytotoxic T cells differentiate intraocular from peripheral blood immune responses in posterior uveitis
by: Kaiser Alam, et al.
Published: (2025-01-01)

The Efficacy of Adalimumab Treatment in Pediatric Non-Infectious Uveitis: A Retrospective Cohort Study
by: Kübra Özdemir Yalçınsoy, et al.
Published: (2024-12-01)

Uveitis in spondyloarthritis: current possibilities of anti-inflammatory therapy
by: A. A. Godzenko, et al.
Published: (2025-05-01)

A Study on the Pattern of Uveitis and Any Seasonal Variation in the Incidence of Uveitis at a Tertiary Care Hospital of Delhi, India
by: Hina Kauser, et al.
Published: (2019-01-01)

HLA-B27-associated uveitis: an independent disease or a variant of spondyloarthritis?
by: A. A. Godzenko, et al.
Published: (2020-09-01)

Adalimumab in Focus: Evaluating Effectiveness and Safety in Non-Infectious Uveitis at a Tertiary Referral Center in Türkiye
by: Berru Yargı Özkoçak, et al.
Published: (2025-08-01)

Regulatory T Cell Sub-Populations in Patients with Distinct Autoimmune/Inflammatory Diseases With or Without Inborn Errors of Immunity
by: Sevil Oskay Halacli, et al.
Published: (2025-07-01)

NATURAL REGULATORY T CELLS AND THEIR MOLECULAR MARKER FOXP3 IN FREQUENTLY ILL PRE-SCHOOL CHILDREN LIVING IN AREAS WITH HUMAN-INDUCED IMPACT
by: A. D. Pertseva, et al.
Published: (2013-07-01)

Acute interstitial nephritis and probable Vogt–Koyanagi–Harada disease following COVID-19 infection: a case report
by: Nahid Aslani, et al.
Published: (2025-07-01)

Course of uveitis in patients with ankylosing spondylitis during the interleukin 17 inhibitors therapy
by: A. A. Godzenko, et al.
Published: (2023-10-01)

Peripheral Vasculitis, Intermediate Uveitis and Interferon Use in Multiple Sclerosis
by: Haluk Esgin
Published: (2016-01-01)

Oral, not gut microbiota diversity, reflects the inflammation and neoplasia in patients with uveitis and vitreoretinal lymphoma
by: Michaela Brichova, et al.
Published: (2025-08-01)

“Infectious uveitis: a comprehensive systematic review of emerging trends and molecular pathogenesis using network analysis”
by: Muhammad Arif Asghar, et al.
Published: (2024-11-01)

Case Report: Acute Unilateral Uveitis Induced by Infusion of Zoledronic Acid
by: Kadir Songür, et al.
Published: (2022-08-01)

Torpid course of the “uveitis — glaucoma — hyphema” syndrome
by: E. V. Gromakina, et al.
Published: (2025-03-01)

Autoimmune hemolytic anemia: the current state of the issue
by: P. I. Vasilchenkova, et al.
Published: (2023-05-01)

Specific features of diagnosis of ankylosing spondylitis in the presence of uveitis in persons of different sex
by: A. P. Rebrov, et al.
Published: (2014-12-01)

Targeted regulatory T cell activation by site-specific PEGylated interleukin-2 mitigates autoimmune inflammation
by: Masahiro Ikeda, et al.
Published: (2025-12-01)

Treatment of chronic lymphocytic leukaemia and autoimmune complications with antibody targeted to the CD52 antigen (Campath) - the first Russian experience
by: T. E. Byalik, et al.
Published: (2022-11-01)

Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2016-09-01)

MiR-425-5p intervenes in autoimmune myocarditis by regulating Treg cell differentiation through NRAS
by: Shan Zhou, et al.
Published: (2025-05-01)

A HISTORY CASE OF ADALIMUMAB TREATMENT IN A FEMALE PATIENT WITH JUVENILE ARTHRITIS AND UVEITIS AS MANIFESTATIONS OF CROHN’S DISEASE
by: V. A. Malievskii, et al.
Published: (2013-07-01)

Comparative effectiveness of various immunosuppressive therapy regimens for uveitis in patients with Behçet’s disease
by: T. A. Lisitsyna, et al.
Published: (2021-05-01)

СLINICAL FEATURES, DIAGNOSIS AND TREATMENT OF PATIENTS WITH RETINAL DETACHMENT DUE TO ACUTE RETINAL NECROSIS
by: S. V. Sdobnikova, et al.
Published: (2017-10-01)

LATE DIAGNOSIS OF UVEITIS IN A GIRL WITH BEHСET'S DISEASE: DEMONSTRATION OF A CLINICAL CASE
by: Z. S. Alekberova, et al.
Published: (2017-01-01)